Hirsutism Treatment Market Regional Outlook, Sales Insights, Cost Structure Analysis, Future Trends and Segmentation By 2023

Research Reports

Jan 25, 2021

Hirsutism Treatment Market Overview

Speaking of effective treatment options for hirsutism, birth control pills are considered to be one of the best options as they elevate the sex hormone-binding globulin. This helps in bringing down the levels of free androgen. As there is no specific approved drug available to treat hirsutism, birth control pills are generally considered to be a first-line medication choice for hirsutism, mostly in women that desire contraception. In the United States (U.S.), various androgen-blocking birth control pills are available that help treat hirsutism, such as YAZ, YASMIN, and OCELLA, which contains spironolactone and drospirenone.

The market is set to touch the valuation of USD 5295.0 million by 2023. Market Research Future (MRFR) reveals that the global hirsutism treatment market could attain a CAGR of 13.6% during the forecast period (2017-2023). Almost three-fourths of women suffering from PCOS are afflicted with hirsutism owing to high secretion of androgen. Other causes of hirsutism include a side effect of certain medications such as androgen therapy which has dehydroepiandrosterone (DHEA), testosterone, as well as the drug, danazol. With the surge in risk factors that accelerate cases of hirsutism, the demand for hirsutism treatment is expected to rise in the subsequent years.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/3857

With an expanding population following poor lifestyle habits and the rising onset of modernization, different types of androgen-related disorders are getting a boost all over the world. PCOS stands as a significant androgen disorder that leads to menstrual irregularities. Rising number of procedures, mounting awareness about treatments, surging personal care expenditure, and constant technological innovations are stimulating market growth. Plus, increasing R&D, along with continuous product development, also leave a positive impact on the overall market.

Hirsutism Treatment Market Prominent Companies

Prominent companies in the worldwide hirsutism treatment market include Allergan (Republic of Ireland), Pfizer Inc. (US), Jubilant Cadista (US), AbbVie Inc. (US), Sun Pharmaceutical Industries Ltd. (India), Bayer AG (Germany), Bristol-Myers Squibb Company (US), and others.

Hirsutism Treatment Market Segmentation

The global hirsutism treatment market has been segmented on the basis of type, diagnosis, treatment, and end-user.

Type-wise, the market comprises idiopathic hirsutism, secondary hirsutism, and others.

Depending on the diagnosis, the market is considered for blood tests, imaging tests, physical examination, and others. Types of blood tests are DHEA-sulfate test, testosterone level test, and others. Imaging test types are CT scan, ultrasound, and others. The physical examination segment caters to auscultation, inspection, palpation and percussion, and others.

With respect to the treatment, the market can be broken down into medications, procedures, and others. Medication has been narrowed down to oral contraceptives, anti-androgens, topical cream, and others. Types of procedures are electrolysis, laser therapy, and others.

The end-users in the market are medical research centers, hospitals and clinics, academic institutes, and others.

Hirsutism Treatment Market Regional Insights

Middle East & Africa, Europe, Asia Pacific, and the Americas have been identified as the main hirsutism treatment market.

The Americas stands as the most profitable market for hirsutism treatment, with North America controlling the major share. The regional market benefits from the rising cases of chronic conditions along with associated risk factors. Moreover, the high per capita disposable income gives ways to high spending on personal care, which works in favor of the regional market.

The United Kingdom (UK) is said to be the fastest expanding market for hirsutism treatment in Europe. Technological advancement, combined with surging demand for treatments, has triggered market growth in the region. Europe has emerged as the second leading market for hirsutism treatment.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/hirsutism-treatment-market-3857

Given the mounting awareness, surging healthcare expenditure, and high availability of cheap healthcare facilities, Asia Pacific is touted to note the fastest growth in the hirsutism treatment market.

Middle East and Africa managed to accumulate the least share in the market and could grow, albeit at a slow rate in the coming years.

Browse Related Reports at:

Absorbable Surgical Sutures Market Outlook | Demand Overview, Share Analysis and Industry Forecast to 2023

Malaria Diagnostics Market Share, Techniques, Trends, Growth Analysis, Industry Forecast to 2023

Negative Pressure Wound Therapy Market Share, Industry Trends and Forecast to 2023

Smart Pills Market Growth Opportunity By Application, Size and Trends

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Tags: Hirsutism Treatment Industry, Hirsutism Treatment Market Trends, Hirsutism Treatment Market Growth, hirsutism treatment market size, hirsutism treatment market share, Hirsutism Treatment Market Insights, Hirsutism Treatment Market Dynamics, Hirsutism Treatment Market Key Players See Campaign: https://www.marketresearchfuture.com/reports/hirsutism-treatment-market-3857
Contact Information:
Akash Anand Market Research Future +1 646 845 9312 Email: [email protected]